BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$860M |
| 3 |
Apple
AAPL
|
+$839M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$830M |
| 5 |
GE Aerospace
GE
|
+$800M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$362M |
| 2 |
Tesla
TSLA
|
+$288M |
| 3 |
NVIDIA
NVDA
|
+$265M |
| 4 |
MetLife
MET
|
+$261M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Consumer Discretionary | 8.14% |
| 3 | Financials | 7.71% |
| 4 | Healthcare | 6.1% |
| 5 | Communication Services | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4701
Solarmax Technology
SMXT
$21.4M
| $8.58K | ﹤0.01% |
441
-2,457
| -85% | -$35.2K |
|
4702
VanEck Morningstar Wide Moat ETF
MOAT
$12.5B
| $8.53K | ﹤0.01% |
92
-318
| -78% | -$30.6K |
|
4703
iShares Core S&P US Growth ETF
IUSG
$34B
| $8.5K | ﹤0.01% |
61
+17
| +39% | +$2.33K |
|
4704
Roadzen
RDZN
$115M
| $8.36K | ﹤0.01% |
+3,835
| New | +$4.74K |
|
4705
ICL Group
ICL
$6.97B
| $8.16K | ﹤0.01% |
+1,652
| New | +$7.39K |
|
|
FORTY
4706
Formula Systems
FORTY
$1.61B
| $8.11K | ﹤0.01% |
100
| – | – |
|
4707
iShares MSCI Thailand ETF
THD
$355M
| $7.92K | ﹤0.01% |
131
-85
| -39% | -$5.5K |
|
|
MRDN
4708
Meridian Holdings Inc
MRDN
$181M
| $7.9K | ﹤0.01% |
+333
| New | +$9.28K |
|
|
MURA
4709
DELISTED
Mural Oncology
MURA
| $7.82K | ﹤0.01% |
2,427
-25,621
| -91% | -$90.3K |
|
|
TECX
4710
Tectonic Therapeutic
TECX
$704M
| $7.8K | ﹤0.01% |
+169
| New | +$7.15K |
|
4711
Tower Semiconductor
TSEM
$29.7B
| $7.78K | ﹤0.01% |
151
-303
| -67% | -$14.2K |
|
4712
First Community Corp
FCCO
$324M
| $7.63K | ﹤0.01% |
318
+221
| +228% | +$5.28K |
|
4713
VirTra
VTSI
$38M
| $7.61K | ﹤0.01% |
1,127
-3,908
| -78% | -$26.4K |
|
|
TSBX
4714
DELISTED
Turnstone Biologics
TSBX
| $7.57K | ﹤0.01% |
+15,238
| New | +$7.53K |
|
4715
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
| $7.49K | ﹤0.01% |
96
-606,335
| -100% | -$47.6M |
|
4716
WhiteHorse Finance
WHF
$152M
| $7.47K | ﹤0.01% |
+772
| New | +$8.49K |
|
|
JF
4717
J and Friends Holdings
JF
$18.1M
| $7.47K | ﹤0.01% |
+8,300
| New | +$7.88K |
|
4718
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $7.46K | ﹤0.01% |
185
-472
| -72% | -$19.5K |
|
4719
FibroBiologics
FBLG
$7.79M
| $7.39K | ﹤0.01% |
185
-86
| -32% | -$4.62K |
|
4720
Senseonics Holdings Inc
SENS
$424M
| $7.37K | ﹤0.01% |
704
| – | – |
|
4721
Purple Innovation
PRPL
$28.3M
| $7.34K | ﹤0.01% |
376
-136
| -27% | -$3.08K |
|
4722
Actinium Pharmaceuticals
ATNM
$26.7M
| $7.24K | ﹤0.01% |
+5,744
| New | +$8.91K |
|
4723
Galectin Therapeutics
GALT
$329M
| $7.22K | ﹤0.01% |
5,600
+145
| +3% | +$348 |
|
|
ONCY
4724
Oncolytics Biotech
ONCY
$96.3M
| $7.13K | ﹤0.01% |
7,800
-5,911
| -43% | -$6.15K |
|
|
ZEPP
4725
Zepp Health
ZEPP
$77.7M
| $7.08K | ﹤0.01% |
2,725
+200
| +8% | +$632 |
|
Similar funds
BNP Paribas Financial Markets's Q4 2024 Portfolio in Review
As of Q4 2024, BNP Paribas Financial Markets held 5,601 positions worth $178B, up 20% from $149B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets deployed $23.8B of net new capital in Q4 2024, opening 1,444 new positions and adding to 1,732 existing holdings. Its largest new stake was GE Aerospace: 4,486,125 shares worth $748M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Utilities Select Sector SPDR ETF, an estimated $362M trimmed.
- BNP Paribas Financial Markets's largest Q4 2024 buy was GE Aerospace: 4,486,125 shares worth $748M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $1.7B increase.
- BNP Paribas Financial Markets's biggest Q4 2024 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $362M.
- BNP Paribas Financial Markets fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2024, selling an estimated $34M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $178B portfolio in Q4 2024.
- BNP Paribas Financial Markets opened 1,444 new positions and closed 206 in Q4 2024.
- BNP Paribas Financial Markets's portfolio value rose 20% quarter-over-quarter to $178B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2024, filed 14 Feb 2025.